Related Experiment Video
Updated: Jun 21, 2026

Establishment and Evaluation of a Porcine Vein Graft Disease Model
Published on: July 25, 2022
Uric acid levels and outcome from coronary artery bypass grafting
Graham S Hillis1, Brian H Cuthbertson, Patrick H Gibson
1Department of Cardiology, University of Aberdeen and Aberdeen Royal Infirmary, Aberdeen, United Kingdom. ghillis@george.org.au
Insights
Elevated serum uric acid levels predict poorer survival after coronary artery bypass grafting (CABG). Higher uric acid is linked to increased mortality risk, independent of other cardiac surgery risk factors.
Area of Science:
- Cardiology
- Biochemistry
- Surgical Outcomes
Background:
- Elevated uric acid is linked to adverse cardiovascular outcomes.
- The prognostic value of uric acid in coronary artery bypass grafting (CABG) patients is unknown.
Purpose of the Study:
- To investigate the association between serum uric acid levels and outcomes in patients undergoing CABG.
- To determine if uric acid is an independent predictor of mortality after CABG.
Main Methods:
- Prospective cohort study of 1140 patients undergoing non-emergency CABG.
- Serum uric acid measured preoperatively.
- Primary endpoint: all-cause mortality assessed over a median of 4.5 years.
Main Results:
- 126 deaths (11%) occurred during follow-up.
- Higher mean uric acid levels in non-survivors (390 ± 131 µmol/L) vs. survivors (353 ± 86 µmol/L).
- Elevated uric acid (≥410 µmol/L) significantly predicted mortality, even after adjusting for European System for Cardiac Operative Risk Evaluation (EuroSCORE).
Conclusions:
- Increasing serum uric acid levels are associated with reduced survival post-CABG.
- Uric acid serves as an independent prognostic marker for mortality after coronary artery bypass grafting.
- This finding adds to the understanding of cardiovascular risk stratification in surgical patients.
Objective:
Elevated uric acid levels have been associated with an adverse cardiovascular outcome in several settings. Their utility in patients undergoing surgical revascularization has not, however, been assessed. We hypothesized that serum uric acid levels would predict the outcome of patients undergoing coronary artery bypass grafting.
Methods:
The study cohort consisted of 1140 consecutive patients undergoing nonemergency coronary artery bypass grafting. Clinical details were obtained prospectively, and serum uric acid was measured a median of 1 day before surgery. The primary end point was all-cause mortality.
Results:
During a median of 4.5 years, 126 patients (11%) died. Mean (+/- standard deviation) uric acid levels were 390 +/- 131 micromol/L in patients who died versus 353 +/- 86 micromol/L among survivors (hazard ratio 1.48 per 100 micromol/L; 95% confidence interval, 1.25-1.74; P < .001). The excess risk associated with an elevated uric acid was particularly evident among patients in the upper quartile (>or=410 micromol/L; hazard ratio vs all other quartiles combined 2.18; 95% confidence interval, 1.53-3.11; P < .001). After adjusting for other potential prognostic variables, including the European System for Cardiac Operative Risk Evaluation, uric acid remained predictive of outcome.
Conclusion:
Increasing levels of uric acid are associated with poorer survival after coronary artery bypass grafting. Their prognostic utility is independent of other recognized risk factors, including the European System for Cardiac Operative Risk Evaluation.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Kidney Injury IV: Diagnostic Studies and Prevention
